Hypothesis\nDuring slow-wave sleep, reduced ERK1/2 nuclear translocation promotes cytoplasmic retention, which activates autophagy and synergizes with glymphatic influx to clear senescent neurons and their SASP factors. Wakefulness sustains ERK nuclear signaling, inhibiting autophagy and limiting clearance, thereby allowing accumulation of damaged neural components.\n\n## Mechanistic Model\n1. Sleep state shift – Slow-wave sleep expands interstitial space (14%→23%) and boosts CSF influx, enhancing glymphatic flow [3]. Concurrently, neuronal activity drops, lowering MAPK cascade input.\n2. ERK1/2 dynamics – Reduced upstream Ras‑Raf‑MEK signaling favors cytoplasmic ERK1/2 phosphatase activity (e.g., MKPs) and impairs its phosphorylation‑dependent nuclear import [1]. Cytoplasmic ERK1/2 retains its ability to phosphorylate autophagy initiators such as ULK1 and Beclin‑1, promoting autophagosome formation [2].\n3. Coupled clearance – Autophagy degrades intracellular senescent cargo (mitochondria, lysosomes, protein aggregates) while glymphatic flow removes extracellular debris, SASP cytokines, and apoptotic bodies. The combined action reduces senescent cell burden in regions like substantia nigra [5].\n4. Wakefulness counter‑phase – During wake, heightened synaptic activity sustains ERK phosphorylation, drives nuclear ERK1/2, which phosphorylates transcription factors (e.g., ELK1, c‑Fos) that upregulate p21^CIP1^ and SASP components, suppressing autophagy via mTORC1 activation and limiting glymphatic efficiency due to contracted interstitial space.\n\n## Testable Predictions\n- Prediction 1: Pharmacological inhibition of MEK (e.g., PD0325901) during wake will mimic sleep‑like ERK cytoplasmic retention and increase autophagic flux (LC3‑II/I ratio) and glymphatic tracer influx in mice.\n- Prediction 2: Genetic overexpression of a nuclear‑localized ERK2 (ERK2‑NLS) will blunt sleep‑induced autophagy and glymphatic clearance, leading to accumulation of p16^INK4a^‑positive senescent cells after chronic sleep fragmentation.\n- Prediction 3: In vivo two‑photon imaging of CSF‑tracer influx combined with immunostaining for phospho‑ERK (nuclear vs cytoplasmic) will show an inverse correlation: high nuclear p‑ERK during wake, low during slow‑wave sleep, and this correlation will be disrupted in AQP4‑knockout mice.\n- Prediction 4: Senolytic treatment (e.g., dasatinib+quercetin) will rescue cognitive deficits caused by sleep deprivation only when ERK nuclear signaling is concurrently suppressed, indicating that ERK drives the senescence that sleep normally clears.\n\n## Experimental Approach\n- Use mice expressing ERK‑KTR (kinase translocation reporter) to monitor ERK nucleocytoplasmic dynamics across sleep‑wake cycles via fiber‑photometry.\n- Measure glymphatic function with intrathecal injection of fluorescent dextran and quantify cortical clearance during sleep vs wake.\n- Assess autophagy using tandem mCherry‑GFP‑LC3 reporter and western blot for LC3‑II, p62.\n- Quantify senescent cell burden via SA‑β‑gal staining and p16 immunohistochemistry in substantia nigra and cortex.\n- Apply sleep fragmentation or optogenetic enhancement of slow waves to test causality.\n\nIf the data show that sleep‑dependent ERK cytoplasmic retention is necessary and sufficient for the coupled autophagic‑glymphatic clearance of senescent material, the hypothesis will be supported. Conversely, if ERK nuclear status does not change with sleep state or manipulating ERK localization fails to alter clearance or senescent load, the hypothesis will be falsified.